版本:
中国

BRIEF-Trillium reports qtrly basic and diluted loss per common share $1.46

May 12 Trillium Therapeutics Inc:

* Trillium reports first quarter 2017 financial and operating results

* Qtrly basic and diluted loss per common share $1.46

* Trillium Therapeutics- net loss for three months ended March 31, 2017 of $11.5 million was higher than loss of $7.2 million for three months ended March 31, 2016

* Qtrly net loss was higher due mainly to increased research and development program expenses of $2.8 million

* All figures in C$ Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐